Industry experts discuss how reshoring, fill/finish capacity, and cold chain technology are shaping a more resilient biopharma supply chain.
Ryan Last
Advertisement
Ryan Last, JD, is an associate at Troutman Pepper Locke.
Articles by Ryan Last
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Iovance’s Lifileucel Reaches 52% Response Rate in Biomarker-Selected Lung Cancer Subgroup
2
Lilly’s Retatrutide Doubles Ozempic’s Weight Loss in First Phase 3 Head-to-Head Trial
3
Genmab’s Petosemtamab Plus Pembrolizumab Cuts Risk of Death by 50% in Phase 3 Head and Neck Cancer Trial
4
Astellas Takes Option on Audax IL-12 Antibody-Cytokine Fusion DAX-044
5